Epidemiology of Sleep Disordered Breathing in Children and Young People With Cerebral Palsy
Launched by UNIVERSITY OF EDINBURGH · Dec 11, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how common sleep breathing problems, known as sleep disordered breathing (SDB), are in children and young people with cerebral palsy (CP). CP is a condition that affects movement and often begins at or shortly after birth. Children with CP are more likely to have sleep issues that can make them feel tired during the day and may affect their learning and heart health. The study aims to find out how many children with CP are using respiratory support, like a special mask that helps them breathe better while they sleep, and to identify new cases of SDB.
To participate in the trial, children must be 16 years old or younger and have a confirmed diagnosis of cerebral palsy. The study will look at two groups: those currently on respiratory support and those who have recently been diagnosed with SDB or started using respiratory support in the past month. Participants will help researchers understand how socio-economic factors influence access to sleep services and what challenges families face when starting these treatments. This knowledge is important as it can lead to better care and support for children with CP and their families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cases for Prevalence survey;
- • Any child aged ≤16 years old, with a confirmed diagnosis of cerebral palsy
- • On respiratory support on the date of prevalence survey
- • Cases for Incidence self-reporting form;
- • Part A;
- • Any Child aged ≤16 years old, with confirmed diagnosis of cerebral palsy
- • Had sleep studies for suspected sleep disordered breathing within the preceding calendar month
- • Part B;
- • Any Child aged ≤16 years old, with a confirmed diagnosis of cerebral palsy
- • Initiated respiratory support (CPAP or NIV or invasive tracheostomy ventilation) in the preceding month
- • Exclusion Criteria: (For prevalence survey and incidence self-reporting form)
- • Any patient aged \>16 years old
- • Patient does not have a confirmed diagnosis of cerebral palsy
About University Of Edinburgh
The University of Edinburgh, a prestigious institution renowned for its commitment to research excellence and innovation, serves as a leading clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a strong emphasis on multidisciplinary collaboration, the university facilitates cutting-edge clinical studies that aim to explore novel therapies and improve patient outcomes. Leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, the University of Edinburgh is at the forefront of translating scientific discoveries into practical applications, thereby contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edinburgh, Edinbrugh, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported